Nabavi, Seyed Mohammad2020-05-082020-05-082018-09Shirooie, S., Nabavi, S.F., Dehpour, A.R., Belwal, T., Habtemariam, S., Argüelles Castilla, S. y Nabavi, S.M. (2018). Targeting mTORs by omega-3 fatty acids: a possible novel therapeutic strategy for neurodegeneration?. Pharmacological Research, 135, 37-48.1043-6618https://hdl.handle.net/11441/96286Neurodegenerative diseases (NDs) such as Parkinson's (PD), Alzheimer's (AD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) cause significant world-wide morbidity and mortality. To date, there is no drug of cure for these, mostly age-related diseases, although approaches in delaying the pathology and/or giving patients some symptomatic relief have been adopted for the last few decades. Various studies in recent years have shown the beneficial effects of omega-3 poly unsaturated fatty acids (PUFAs) through diverse mechanisms including anti-inflammatory effects. This review now assesses the potential of this class of compounds in NDs therapy through specific action against the mammalian target of rapamycin (mTOR) signaling pathway. The role of mTOR in neurodegenerative diseases and targeted therapies by PUFAs are discussed.application/pdf11 p.engAttribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Neurodegenerative diseasesmTORomega-3Docosahexaenoic acidEicosapentaenoic acidinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccess10.1016/j.phrs.2018.07.00421599743